查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938794

動物咀嚼片市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、藥物、通路、地區及競爭格局分類，2021-2031年）

Animal Chewables Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Composition Type, By Drug, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸用咀嚼片市場預計將從 2025 年的 1.5 億美元成長到 2031 年的 2.3 億美元，複合年成長率為 7.38%。

這些產品是偏好的口服給藥系統，旨在透過咀嚼的方式餵食寵物、補充營養或進行牙齒護理。市場成長的主要驅動力是寵物飼主對寵物的日益人性化以及他們在預防保健和高階健康產品上的支出增加。此外，慢性獸醫疾病的增加也推動了對易於給藥、確保寵物和飼主都能輕鬆遵從的治療方法的需求。這些因素預示著寵物保健正在發生永久性的變革，而非曇花一現的趨勢。

市場概覽
預測期 2027-2031
市場規模：2025年 1.5億美元
市場規模：2031年 2.3億美元
複合年成長率：2026-2031年 7.38%
成長最快的細分市場 化學合成
最大的市場 北美洲

阻礙市場發展的主要障礙之一是複雜的法規環境，尤其是在安全性和有效性聲明方面，各國監管標準差異顯著。由於需要進行嚴格的測試來證明新配方的穩定性和口感，企業常常面臨代價高昂的延誤。根據美國寵物用品協會 (APPA) 預測，到 2024 年，一半的狗主飼主大約三分之一的貓飼主會給他們的寵物服用營養補充劑或維生素。如此高的使用率凸顯了消費者對便捷服用方式的強烈需求，但嚴格的合規標準仍阻礙新型咀嚼片產品快速進入全球市場。

市場促進因素

寵物人性化和優質化的趨勢日益明顯，飼主將寵物視為家庭成員，並努力為其提供最高標準的醫療保健，這正在改變全球動物咀嚼片市場。這種情感紐帶推動了消費者對高階健康產品的大量支出，並促使他們的偏好從基本食品轉向更先進、偏好的藥物和營養補充劑輸送系統。根據美國寵物產品協會 (APPA) 於 2025 年 3 月發布的《2025 年產業趨勢報告》，美國寵物產業的支出將在 2024 年達到 1,520 億美元，這表明飼主已準備好在動物福利方面進行大量投資。在不斷成長的寵物擁有率（包括澳洲動物醫學協會 2025 年 9 月發布的《澳洲寵物》報告中指出的 73% 的家庭寵物普及率）的支持下，這些趨勢正在推動高階咀嚼片的研發，其品質可與人類營養補充劑相媲美。

第二個關鍵促進因素是功能性和營養補充劑需求的成長，這使得咀嚼片成為預防保健的首選形式。隨著寵物飼主將永續的健康維護置於被動治療之上，用於緩解焦慮、改善關節活動度和維護牙齒健康的口腔產品的消費量顯著增加。軟性咀嚼片的偏好和易用性使其比標準片劑更能有效地維持日常護理。這種轉變也反映在財務表現上。維克公司於2025年1月發布的「2024年第四季合併銷售報告」顯示，經外匯調整後，其伴侶動物部門的銷售額成長了10.7%，這主要得益於其牙科產品線和特種產品的強勁成長。為了應對這一趨勢，製造商正在開發採用疾病特異性配方和天然成分的產品，以搶佔不斷擴大的預防性護理市場。

市場挑戰

複雜的成分安全性和功效聲明監管框架對全球獸用咀嚼片市場的發展構成重大障礙。生產商必須遵守不同的區域標準，這些標準通常要求針對特定市場採用獨特的配方和額外的測試通訊協定。與傳統片劑不同，咀嚼片必須經過嚴格的穩定性和偏好檢驗，以確保活性成分即使與香料混合也能保持效力。這種全球統一性的缺失顯著增加了研發所需的資金和時間，迫使企業將過多資源用於合規而非創造性。

這種監管瓶頸限制了新產品的上市速度，阻礙了市場充分利用對便利用藥劑型日益成長的需求。根據歐洲動物健康協會（AnimalhealthEurope）的數據，歐洲藥品管理局（EMA）在2024年僅核准了25種新的動物用藥品。歐盟範圍內如此少的核准數量凸顯了製造商在將符合規定的創新產品推向市場方面面臨的巨大挑戰。因此，沉重的合規負擔成為限制市場成長的障礙，並減緩了新型咀嚼片療法在消費者中的廣泛應用。

市場趨勢

多功能複合咀嚼片的興起正成為寵物飼主的一大趨勢，他們希望將複雜的營養補充方案簡化為單一、易用的劑型。隨著功能性產品需求的成長，消費者正逐漸拋棄多種單一成分的產品，轉而選擇能夠同時支持免疫功能、腸道健康和關節健康的「全效合一」軟性咀嚼片。這種轉變的驅動力源於家庭對成本效益的追求以及減少寵物「服藥疲勞」的需求，迫使製造商開發更具相容性的活性成分配方。 2025年4月發布的GlobalPETS報告《Zesty Paws品牌所有者揭示寵物營養與照護是主要收入來源》印證了這項轉變的商業性可行性。報告指出，Zesty Paws品牌預計在2024會計年度實現11.8%的收入成長，這主要得益於其多功能軟咀嚼片產品線的成功。

同時，對可生物分解和永續包裝的關注正迅速成為關鍵的競爭因素。隨著環保意識日益增強的消費者越來越關注一次性塑膠袋對環境的影響，這一趨勢正在從根本上改變寵物咀嚼包裝和供應鏈。企業被迫從傳統的金屬化聚酯薄膜轉向消費後回收和可堆肥材料，同時也要維持對產品穩定性至關重要的防潮性能。消費者的偏好凸顯了這項轉變的迫切性。根據DC Pet Distribution於2025年5月發布的《2025年寵物產業永續包裝趨勢》報告，約70%的美國寵物飼主現在更傾向於選擇那些透過可堆肥或可回收包裝來展現其永續性承諾的品牌。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球動物咀嚼片市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依成分類型（植物來源合成、化學合成）
    • 透過藥物治療（止痛藥、抗感染劑、抗潰瘍藥、礦物質、維生素）
    • 按分銷管道（線上獸醫診所商店、獸醫診所、獸藥店）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美動物咀嚼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲動物咀嚼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區動物咀嚼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲動物咀嚼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲動物咀嚼片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球動物咀嚼片市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Allaccem Inc
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Animal Health LLC
  • Colgate-Palmolive Co
  • Merck & Co., Inc.
  • Nestle SA
  • Zoetis Inc
  • Dechra Veterinary Products Ltd
  • Elanco Animal Health Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19549

The Global Animal Chewables Market is projected to expand from USD 0.15 Billion in 2025 to USD 0.23 Billion by 2031, reflecting a compound annual growth rate of 7.38%. These products function as tasty oral delivery systems designed to administer pharmaceuticals, nutraceuticals, or dental care through the act of chewing. The market's upward trajectory is largely fueled by the growing humanization of pets, encouraging owners to spend on preventative care and high-end wellness items. Additionally, the increase in chronic veterinary issues drives the need for easy-to-administer treatments that ensure adherence without stressing the pet or the handler. These factors mark a permanent evolution in pet health management rather than serving as distinct, temporary fads.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 0.15 Billion
Market Size 2031USD 0.23 Billion
CAGR 2026-20317.38%
Fastest Growing SegmentChemically Synthesized
Largest MarketNorth America

One major hurdle slowing market progress is the complicated regulatory environment concerning safety and efficacy claims, which differs widely across international borders. Companies often encounter expensive delays due to the strict testing needed to prove the stability and taste of new formulas. According to the American Pet Products Association, in 2024, half of all dog owners and nearly one-third of cat owners gave supplements or vitamins to their pets. This significant usage highlights the strong consumer appetite for user-friendly delivery methods, though rigorous compliance standards continue to obstruct the swift introduction of new chewable products to the global stage.

Market Driver

The trends of rising pet humanization and premiumization are transforming the global animal chewables sector, as owners increasingly treat their pets like family members worthy of top-tier healthcare. This emotional connection prompts significant spending on luxury wellness items, moving consumer choices away from basic food toward advanced, palatable delivery systems for medications and supplements. Data from the American Pet Products Association's '2025 State of the Industry Report' in March 2025 indicates that U.S. pet industry spending hit $152 billion in 2024, demonstrating owners' readiness to invest heavily in animal welfare. Supported by rising ownership rates-such as the 73% household penetration noted in Animal Medicines Australia's September 2025 'Pets in Australia' report-these patterns encourage the creation of premium chewable products that rival human nutraceutical standards.

A second pivotal driver is the escalating demand for functional and nutritional supplements, which has established chewables as the favored format for preventative care. As pet parents prioritize enduring wellness over reactive treatments, consumption of oral products for anxiety, joint mobility, and dental health has risen markedly. The palatability and ease of soft chews make them more effective than standard tablets for maintaining daily routines. This shift is reflected in financial results; Virbac's '2024 fourth quarter consolidated sales' report from January 2025 highlights a 10.7% revenue jump in their companion animal division at constant exchange rates, bolstered by dental ranges and specialty items. In response, manufacturers are innovating with condition-specific formulas and natural ingredients to seize this growing preventative market.

Market Challenge

The intricate regulatory framework governing ingredient safety and efficacy claims acts as a major obstacle to the Global Animal Chewables Market's development. Producers must maneuver through varying standards across different regions, frequently requiring unique formulations or supplementary testing protocols for specific markets. Unlike conventional tablets, chewables demand strict verification of stability and palatability to guarantee that active pharmaceutical ingredients remain potent when combined with flavoring agents. This lack of global harmonization substantially inflates the capital and time needed for research and development, compelling firms to divert excessive resources toward compliance rather than creative innovation.

This regulatory bottleneck restricts the frequency of new product introductions, hindering the market from fully exploiting the growing demand for user-friendly medication forms. Data from AnimalhealthEurope indicates that in 2024, the European Medicines Agency authorized just 25 new animal health products for use. This modest approval volume across the European Union highlights the immense challenges manufacturers encounter in commercializing compliant innovations. Consequently, the heavy burden of compliance functions as a barrier that limits market growth and delays the availability of novel chewable treatments for consumers.

Market Trends

The rise of multifunctional combination chews is becoming a leading trend as pet owners look to streamline complex supplement schedules into single, easy-to-use dosage forms. While demand for functional products grows, consumers are shifting away from multiple single-ingredient items in favor of "all-in-one" soft chews that simultaneously target immune function, gut health, and joint support. This transition is driven by a wish to improve household cost-efficiency and minimize "pill fatigue" for the animal, pushing manufacturers to develop active ingredient matrices that are highly compatible. The commercial viability of this shift is confirmed by the April 2025 GlobalPETS report, 'Zesty Paws owner reveals pet nutrition and care as key revenue contributors,' which notes that the Zesty Paws brand realized an 11.8% revenue increase in fiscal year 2024, largely fueled by the success of their multifunctional soft chew lines.

Concurrently, a focus on biodegradable and sustainable packaging is fast becoming a crucial competitive factor as eco-aware consumers increasingly scrutinize the environmental footprint of single-use plastic pouches. This trend fundamentally changes the presentation and supply chain of chewables, compelling companies to switch from conventional metallized polyester films to post-consumer recycled or compostable materials, all while maintaining the moisture barrier essential for product stability. The urgency of this shift is highlighted by consumer preferences; the DC Pet Distribution 'Sustainable Packaging Trends in the 2025 Pet Industry' report from May 2025 indicates that nearly 70% of U.S. pet owners now prefer brands that show a commitment to sustainability through compostable or recyclable packaging options.

Key Market Players

  • Allaccem Inc
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Animal Health LLC
  • Colgate-Palmolive Co
  • Merck & Co., Inc.
  • Nestle SA
  • Zoetis Inc
  • Dechra Veterinary Products Ltd
  • Elanco Animal Health Inc

Report Scope

In this report, the Global Animal Chewables Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Chewables Market, By Composition Type

  • Botanically Synthesized
  • Chemically Synthesized

Animal Chewables Market, By Drug

  • Analgesics
  • Anti-Infective
  • Anti-Ulcers
  • Minerals
  • Vitamins

Animal Chewables Market, By Distribution Channel

  • Online Veterinary Stores
  • Veterinary Clinics
  • Veterinary Pharmacies

Animal Chewables Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Chewables Market.

Available Customizations:

Global Animal Chewables Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Chewables Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Composition Type (Botanically Synthesized, Chemically Synthesized)
    • 5.2.2. By Drug (Analgesics, Anti-Infective, Anti-Ulcers, Minerals, Vitamins)
    • 5.2.3. By Distribution Channel (Online Veterinary Stores, Veterinary Clinics, Veterinary Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Animal Chewables Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Composition Type
    • 6.2.2. By Drug
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Animal Chewables Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Composition Type
        • 6.3.1.2.2. By Drug
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Animal Chewables Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Composition Type
        • 6.3.2.2.2. By Drug
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Animal Chewables Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Composition Type
        • 6.3.3.2.2. By Drug
        • 6.3.3.2.3. By Distribution Channel

7. Europe Animal Chewables Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Composition Type
    • 7.2.2. By Drug
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Animal Chewables Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Composition Type
        • 7.3.1.2.2. By Drug
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Animal Chewables Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Composition Type
        • 7.3.2.2.2. By Drug
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Animal Chewables Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Composition Type
        • 7.3.3.2.2. By Drug
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Animal Chewables Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Composition Type
        • 7.3.4.2.2. By Drug
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Animal Chewables Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Composition Type
        • 7.3.5.2.2. By Drug
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Animal Chewables Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Composition Type
    • 8.2.2. By Drug
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Animal Chewables Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Composition Type
        • 8.3.1.2.2. By Drug
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Animal Chewables Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Composition Type
        • 8.3.2.2.2. By Drug
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Animal Chewables Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Composition Type
        • 8.3.3.2.2. By Drug
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Animal Chewables Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Composition Type
        • 8.3.4.2.2. By Drug
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Animal Chewables Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Composition Type
        • 8.3.5.2.2. By Drug
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Animal Chewables Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Composition Type
    • 9.2.2. By Drug
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Animal Chewables Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Composition Type
        • 9.3.1.2.2. By Drug
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Animal Chewables Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Composition Type
        • 9.3.2.2.2. By Drug
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Animal Chewables Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Composition Type
        • 9.3.3.2.2. By Drug
        • 9.3.3.2.3. By Distribution Channel

10. South America Animal Chewables Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Composition Type
    • 10.2.2. By Drug
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Animal Chewables Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Composition Type
        • 10.3.1.2.2. By Drug
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Animal Chewables Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Composition Type
        • 10.3.2.2.2. By Drug
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Animal Chewables Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Composition Type
        • 10.3.3.2.2. By Drug
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Animal Chewables Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Allaccem Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bayer AG
  • 15.3. Boehringer Ingelheim GmbH
  • 15.4. Ceva Animal Health LLC
  • 15.5. Colgate-Palmolive Co
  • 15.6. Merck & Co., Inc.
  • 15.7. Nestle SA
  • 15.8. Zoetis Inc
  • 15.9. Dechra Veterinary Products Ltd
  • 15.10. Elanco Animal Health Inc

16. Strategic Recommendations

17. About Us & Disclaimer